Thrive Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Thrive Wealth Management's AMGN Position: Q2 2026 in Review
Thrive Wealth Management reduced its Amgen (AMGN) stake by 0.86% in Q2 2026, selling an estimated $9.59K and leaving 3,218 shares worth $1.17M. The position accounts for 0.15% of the portfolio, ranked #72.
Thrive Wealth Management first reported a position in AMGN in Q2 2022 and has held it in 17 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Thrive Wealth Management held 3,218 shares of Amgen worth $1.17M as of Q2 2026.
- Thrive Wealth Management sold 28 Amgen shares in Q2 2026, an estimated $9.59K.
- Amgen made up 0.15% of Thrive Wealth Management's portfolio in Q2 2026, its #72 holding.
- Thrive Wealth Management first reported a position in Amgen in Q2 2022 and has held it in 17 quarters since.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Thrive Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.